<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03279185</url>
  </required_header>
  <id_info>
    <org_study_id>PH400</org_study_id>
    <secondary_id>PH400</secondary_id>
    <nct_id>NCT03279185</nct_id>
  </id_info>
  <brief_title>Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite</brief_title>
  <acronym>AMP Up Lite</acronym>
  <official_title>Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite (AMP Up Lite)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Office of AIDS Research (OAR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The National Institute of Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The National Institute of Dental and Craniofacial Research (NIDCR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective cohort study designed to define the impact of HIV infection and
      antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition
      to adulthood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort study designed to define the impact of HIV infection and
      antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition
      to adulthood.

      The primary objectives of this study are:

        1. To identify infectious and non-infectious complications of HIV disease and toxicities
           resulting from long-term ART, including disease progression, immune suppression, viral
           resistance, end-organ disease, and mortality.

        2. To define the impact of HIV infection and ART on the long-term clinical outcomes of
           young adults with perinatal HIV.

        3. To define the impact of perinatal HIV infection and ART on long-term mental and
           behavioral health outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HIV Disease Progression</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Factors of interest for this outcome include virologic suppression, immune impairment, immune activation, changes in ART, cumulative exposure to specific ART, viral resistance, co-infections, and host genetic polymorphisms. Data will be collected through chart abstraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Anomalies</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Data will be collected by chart review, physical assessments, and laboratory evaluations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sexually Transmitted Infections</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Data collected through chart abstraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproductive Health</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Data collected through an online surveys and chart abstraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mental Health</measure>
    <time_frame>Annually for 6 years.</time_frame>
    <description>Data collected through an online survey and chart abstraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ART Adherence</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Data collected through an online survey.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk Behaviors (Sexual and Substance Use)</measure>
    <time_frame>Annually for 6 years</time_frame>
    <description>Data collected through an online survey.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transition to Adult Functioning</measure>
    <time_frame>Annually for 6 years.</time_frame>
    <description>Data collected through an online survey.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hearing Dysfunction</measure>
    <time_frame>Annually for 6 years.</time_frame>
    <description>Data collected through an online survey and chart abstraction.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>Infected Cohort</arm_group_label>
    <description>Perinatally HIV-infected participants at or beyond their 18th birthday at enrollment.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, peripheral blood mononuclear cells (PBMCs)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Perinatally HIV-infected (PHIV+) young adults 18 years of age or older at the time of
        enrollment born to HIV-infected mothers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Perinatal HIV infection as documented in the medical record;

          -  At or beyond their 18th birthday at the time of informed consent with no upper age
             limit;

          -  Willingness to provide access to existing medical records; and

          -  Willingness to participate and provide legal consent

        Exclusion Criteria:

          -  Prisoner status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George R Seage, ScD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard T.H. Chan School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katherine Tassiopoulos, DSc, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Harvard T.H. Chan School of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Russell B Van Dyke, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tulane University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie Alperen, DrPH</last_name>
    <phone>617-432-6762</phone>
    <email>jalperen@hsph.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauren E Nisotel, BS</last_name>
    <phone>617-432-0146</phone>
    <email>lnisotel@hsph.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mariam Davtyan, MPH</last_name>
      <phone>323-865-1566</phone>
      <email>mdavtyan@usc.edu</email>
    </contact>
    <investigator>
      <last_name>Toinette Frederick, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>David Geffen School of Medicine at UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele Carter, RN</last_name>
      <phone>301-206-6369</phone>
      <email>mfcarter@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Jaime Deville, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bridget Wynn, MPH</last_name>
      <phone>404-616-2213</phone>
      <email>bridget.wynn@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Rana Chakraborty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Cook County Hospital Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maureen McNichols, RN</last_name>
      <phone>312-572-4541</phone>
      <email>maureen_e_mcnichols@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Mariam Aziz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thuy Anderson, RN</last_name>
      <phone>443-287-8942</phone>
      <email>tander34@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Allison Agwu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debra McLaud, RN</last_name>
      <phone>617-414-5813</phone>
      <email>debra.mclaud@bmc.org</email>
    </contact>
    <investigator>
      <last_name>Stephen Pelton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra Deygoo, MS, CCRP</last_name>
      <phone>212-263-5680</phone>
      <email>nagamah.deygoo@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>William Borkowsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Stony Brook</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>17794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erin Infanzon</last_name>
      <phone>631-444-8832</phone>
      <email>erin.infanzon@stonybrookmedicine.edu</email>
    </contact>
    <investigator>
      <last_name>Sharon Nachman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amanda Robson, BS</last_name>
      <phone>206-884-1535</phone>
      <email>amanda.robson@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Ann Melvin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.phacsstudy.org</url>
    <description>Pediatric HIV/AIDS Cohort Study</description>
  </link>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2017</study_first_submitted>
  <study_first_submitted_qc>September 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2017</study_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard School of Public Health</investigator_affiliation>
    <investigator_full_name>George Seage</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>HIV/AIDS, perinatal HIV infection</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

